Literature DB >> 11034212

Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis.

M Li1, A K Indra, X Warot, J Brocard, N Messaddeq, S Kato, D Metzger, P Chambon.   

Abstract

Nuclear receptors for retinoids (RARs) and vitamin D (VDR), and for some other ligands (TRs, PPARs and LXRs), maybe critical in the development and homeostasis of mammalian epidermis. It is believed that these receptors form heterodimers with retinoid X receptors (RXRs) to act as transcriptional regulators. However, most genetic approaches aimed at establishing their physiological functions in the skin have been inconclusive owing either to pleiotropic effects and redundancies between receptor isotypes in gene knockouts, or to equivocal interpretation of dominant-negative mutant studies in transgenic mice. Moreover, knockout of RXRalpha, the main skin RXR isotype, is lethal in utero before skin formation. Here we have resolved these problems by developing an efficient technique to create spatiotemporally controlled somatic mutations in the mouse. We used tamoxifen-inducible Cre-ER(T) recombinases to ablate RXRalpha selectively in adult mouse keratinocytes. We show that RXRalpha has key roles in hair cycling, probably through RXR/VDR heterodimers, and in epidermal keratinocyte proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034212     DOI: 10.1038/35036595

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  89 in total

1.  Looking at nuclear receptors from the heights of Erice. Workshop on nuclear receptor structure and function.

Authors:  Paolo Ciana; Elisabetta Vegeto; Miguel Beato; Pierre Chambon; Jan-Ake Gustafsson; Malcolm Parker; Walter Wahli; Adriana Maggi
Journal:  EMBO Rep       Date:  2002-02       Impact factor: 8.807

2.  New variants of inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility.

Authors:  F T Wunderlich; H Wildner; K Rajewsky; F Edenhofer
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

3.  Phospholipase Cdelta1 is required for skin stem cell lineage commitment.

Authors:  Yoshikazu Nakamura; Kiyoko Fukami; Haiyan Yu; Kei Takenaka; Yuki Kataoka; Yuji Shirakata; Shin-Ichi Nishikawa; Koji Hashimoto; Nobuaki Yoshida; Tadaomi Takenawa
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

4.  A new start in Madrid. Symposium on basic and translational cancer research.

Authors:  Julio E Celis
Journal:  EMBO Rep       Date:  2002-08       Impact factor: 8.807

Review 5.  Transcriptional control of epidermal specification and differentiation.

Authors:  Xing Dai; Julia A Segre
Journal:  Curr Opin Genet Dev       Date:  2004-10       Impact factor: 5.578

Review 6.  Conditional gene expression in the mouse inner ear using Cre-loxP.

Authors:  Brandon C Cox; Zhiyong Liu; Marcia M Mellado Lagarde; Jian Zuo
Journal:  J Assoc Res Otolaryngol       Date:  2012-04-24

7.  Premature ovarian failure in androgen receptor-deficient mice.

Authors:  Hiroko Shiina; Takahiro Matsumoto; Takashi Sato; Katsuhide Igarashi; Junko Miyamoto; Sayuri Takemasa; Matomo Sakari; Ichiro Takada; Takashi Nakamura; Daniel Metzger; Pierre Chambon; Jun Kanno; Hiroyuki Yoshikawa; Shigeaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

Review 8.  Molecular mechanisms underlying the effects of sex steroids on bone and mineral metabolism.

Authors:  Yuuki Imai; Takashi Nakamura; Takahiro Matsumoto; Kunio Takaoka; Shigeaki Kato
Journal:  J Bone Miner Metab       Date:  2009-01-29       Impact factor: 2.626

9.  The pituitary function of androgen receptor constitutes a glucocorticoid production circuit.

Authors:  Junko Miyamoto; Takahiro Matsumoto; Hiroko Shiina; Kazuki Inoue; Ichiro Takada; Saya Ito; Johbu Itoh; Takeo Minematsu; Takashi Sato; Toshihiko Yanase; Hajime Nawata; Yoshiyuki R Osamura; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

Review 10.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.